Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma

Dr John B Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands

10 Sep 2022

OncoAlert and ecancer weekly round up for August 15th - 21st, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

22 Aug 2022

Working to improve global cancer care access in low middle-income countries

Dr Julie Gralow, Prof Eduardo Cazap

25 Jul 2022

Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer

Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA

20 Jul 2022

ASCO Direct Highlights 2022: prostate cancer highlights

Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA

9 Jul 2022

ASCO Direct Highlights 2022: lung cancer highlights

Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA

9 Jul 2022

Updates in bladder, kidney and testes cancer from ASCO 2022

Dr Winston Tan - Mayo Clinic, Jacksonville, USA

9 Jul 2022

Latest updates in treatment for the field of HER2-positive breast cancer

Dr Delia Guaqueta - Memorial Healthcare System, Hollywood, USA

8 Jul 2022

Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma

Dr Anna Sureda - Blood Cell Barcelona Hematology Institute, Barcelona, Spain

$Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma ( Dr Anna Sureda - Blood Cell Barcelona Hematology Institute, Barcelona, Spain )$

1 Jul 2022

War in Ukraine: Global cancer aid to support refugees

Dr Horia Vulpe , Dr Ruslan Baltaga

21 Jun 2022

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

Kathy Oliver - Chair and Co-Director, International Brain Tumour Alliance

21 Jun 2022

CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma

Dr Carlos Fernández De Larrea - Hospital Clínic de Barcelona, Spain

$CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma ( Dr Carlos Fernández De Larrea - Hospital Clínic de Barcelona, Spain )$

14 Jun 2022

Video

More from ecancer